🇺🇸 FDA
Patent

US 7294480

High throughput screening assays using fatty acid synthetic enzymes

granted A61PA61P1/04A61P1/14

Quick answer

US patent 7294480 (High throughput screening assays using fatty acid synthetic enzymes) held by Xenon Pharmaceuticals Inc. expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/04, A61P1/14, A61P11/00, A61P15/00